Bacteriolytic and bactericidal activity in monocytic and myelomonocytic leukemia with hyperlysozymemia.
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000494:pharmacology; D001770:Blood Bactericidal Activity; D003165:Complement System Proteins / Q000032:analysis; D004926:Escherichia coli; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007951:Leukemia, Myeloid / Q000097:blood* / Q000276:immunology; D008297:Male; D009113:Muramidase / Q000097:blood* / Q000494:pharmacology; D012075:Remission, Spontaneous; D014168:Transferrin / Q000032:analysis
D000970:Antineoplastic Agents; D007136:Immunoglobulins; D014168:Transferrin; D003165:Complement System Proteins; D009113:Muramidase